# US 2013/0253047 A1 · Method and composition for preventing and treating avian influenza in poultry

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253047 A1
- Document ID: US20130253047A1
- Status: Published application
- Kind: A1
- Application number: 13/900,235
- Filed: 2013-05-22
- Published: 2013-09-26
- Earliest claimed: 2006-09-20
- Assignees: Abattis Bioceuticals Corp
- Applicants: Abattis Bioceuticals Corp
- Inventors: Charles Hensley; Sung Pyo
- Web page: https://patentgrep.com/patent/US20130253047A1

## CPC

- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K 36/82: Theaceae (Tea family), e.g. camellia
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method and composition for preventing and treating avian influenza utilizes an effective quantity of polyphenolic(s) and its derivatives in combination with a carrier. The anti-avian influenza ingredient having a composition selected from the group consisting of theaflavin, theaflavin-3,3′-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3′-gallate, thearubigin, gallic acid, tannic acid, (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (+)-epicatechin (EC), (−)-gallocatechin gallate (GCG), and catechin.

## Claims

### Claim 1

A method for treating and reducing the risk of avian influenza in a poultry, comprising a step of administering to said poultry a composition comprising an anti-avian influenza ingredient containing a polyphenolic selected from the group consisting of theaflavin, theaflavin-3,3′-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3′-gallate, thearubigin, gallic acid, tannic acid, (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (+)-epicatechin (EC), (−)-gallocatechin gallate (GCG), catechin, and combinations thereof.

### Claim 2 (depends on 1)

The method of claim 1, wherein the composition comprises the anti-avian influenza ingredient in combination with a carrier.

### Claim 3 (depends on 2)

The method of claim 2, wherein the composition comprises 98.0% by weight of the carrier and 2.0% by weight of the anti-avian influenza ingredient.

### Claim 4 (depends on 1)

The method of claim 1, wherein the polyphenolic is extracted from tea leaves.

### Claim 5 (depends on 3)

The method of claim 3, wherein the polyphenolic is extracted from tea leaves.

### Claim 6 (depends on 1)

The method of claim 1, wherein theaflavin, theaflavin-3,3′-digallate, theaflavin-3 gallate, thearubigin, gallic acid, and tannic acid are extracted from black tea.

### Claim 7 (depends on 3)

The method of claim 3, wherein theaflavin, theaflavin-3,3′-digallate, theaflavin-3 gallate, thearubigin, gallic acid, and tannic acid are extracted from black tea.

### Claim 8 (depends on 1)

The method of claim 1, wherein (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (−)epicatechin gallate (ECG), (+)-epicatechin (EC), (−)gallocatechin gallate (GCG), and catechin are extracted from green tea.

### Claim 9 (depends on 3)

The method of claim 3, wherein (−)-epigallocatechin gallate (EGCG), (−)epigallocatechin (EGC), (−)epicatechin gallate (ECG), (+)-epicatechin (EC), (−)gallocatechin gallate (GCG), and catechin are extracted from green tea.

### Claim 10 (depends on 1)

The method of claim 1, wherein the composition is administered directly to poultry by ingestion.

### Claim 11 (depends on 5)

The method of claim 5, wherein the composition is administered directly to poultry by ingestion.

### Claim 12 (depends on 1)

The method of claim 1, wherein the composition is administered directly to poultry by inhalation.

### Claim 13 (depends on 5)

The method of claim 5, wherein the composition is administered directly to poultry by inhalation.

### Claim 14 (depends on 1)

The method of claim 1, wherein the composition is administered directly to poultry by injection.

### Claim 15 (depends on 5)

The method of claim 5, wherein the composition is administered directly to poultry by injection.
